| Dataset | DGIdb Drug Targets 2026 |
| Category | physical interactions |
| Type | drug |
| Description | An oxopurine that is theophylline bearing a 2,3-dihydroxypropyl group at the 7 position. It has broncho- and vasodilator properties, and is used in the treatment of asthma, cardiac dyspnea, and bronchitis. It is also an ingredient in preparations that have been promoted for coughs. (Chemical Entities of Biological Interest Ontology, CHEBI_4728) |
| External Link | https://dgidb.org/results?searchType=drug&searchTerms=DYPHYLLINE |
| Similar Terms | |
| Downloads & Tools |
7 interacting proteins for the DYPHYLLINE drug from theDGIdb Drug Targets 2026 dataset.
| Symbol | Name | Standardized Value |
|---|---|---|
| PDE7B | phosphodiesterase 7B | 2.52057 |
| PDE7A | phosphodiesterase 7A | 2.16049 |
| PDE4C | phosphodiesterase 4C, cAMP-specific | 0.66721 |
| PDE4A | phosphodiesterase 4A, cAMP-specific | 0.521497 |
| PDE4B | phosphodiesterase 4B, cAMP-specific | 0.371888 |
| PDE4D | phosphodiesterase 4D, cAMP-specific | 0.32877 |
| PDE3A | phosphodiesterase 3A, cGMP-inhibited | 0.270061 |
